Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...
Tags: Japan, approval, anticoagulant, subanalysis